Status:
COMPLETED
A Study of MIcrocirculatory Perfusion Alterations in Severe Burn Injury
Lead Sponsor:
Maasstad Hospital
Conditions:
Microcirculation
Burns
Eligibility:
All Genders
18+ years
Brief Summary
The main objective of our study is to focus on the efficiency of standard fluid resuscitation in promoting tissue perfusion in severe burns patients (\>15% TBSA). The incidence of microcirculatory per...
Detailed Description
Rationale: There are valid concerns that resuscitation in burns shock is inadequate. A tendency to over resuscitate patients seem to exist. Current guidelines were developed 35 years ago and clinical ...
Eligibility Criteria
Inclusion
- ICU admission with a severe burn injuries of ≥15% TBSA
- ≥ 18 years of age
- Receiving standard resuscitation protocol for severe burn injury
- Post burn time up to a maximum of 24 hours
Exclusion
- Informed consent not obtained
- (suspected) generalised infection
- Other traumatic injury, which is supposed to generate a systemic inflammatory response eg severe fractures, or other types of shock as a result of massive bleeding
- Patients unlikely to survive \>24 hours
- Decision not to initiate treatment
Key Trial Info
Start Date :
November 12 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 15 2020
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT04500197
Start Date
November 12 2018
End Date
September 15 2020
Last Update
October 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maasstad Hospital
Rotterdam, Zuid Nederland, Netherlands, 3079DZ